vs
Purple Innovation, Inc.（PRPL）与Vericel Corp（VCEL）财务数据对比。点击上方公司名可切换其他公司
Purple Innovation, Inc.的季度营收约是Vericel Corp的1.5倍（$140.7M vs $92.9M），Vericel Corp净利率更高（25.0% vs -2.3%，领先27.3%），Vericel Corp同比增速更快（23.3% vs 9.1%），Vericel Corp自由现金流更多（$12.8M vs $-7.8M），过去两年Vericel Corp的营收复合增速更高（34.6% vs 8.3%）
Purple Carrot是一家总部位于马萨诸塞州尼达姆市的全植物性餐包品牌，由安迪·莱维特创立，每周为订阅用户提供预制餐品和自制餐包。据《大都会》2022年报道，对比美式标准餐食，该品牌每份餐包的碳排放量可降低72%，主打低碳环保的纯植物饮食方案。
Vericel Corp是一家美国上市生物制药企业，前身为1989年在密歇根州安娜堡成立的Aastrom Bio，2014年10月正式更为现名，专注于生物制药相关领域的研发与商业化运营。
PRPL vs VCEL — 直观对比
营收规模更大
PRPL
是对方的1.5倍
$92.9M
营收增速更快
VCEL
高出14.2%
9.1%
净利率更高
VCEL
高出27.3%
-2.3%
自由现金流更多
VCEL
多$20.6M
$-7.8M
两年增速更快
VCEL
近两年复合增速
8.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $140.7M | $92.9M |
| 净利润 | $-3.2M | $23.2M |
| 毛利率 | 41.9% | 78.7% |
| 营业利润率 | -1.6% | 24.1% |
| 净利率 | -2.3% | 25.0% |
| 营收同比 | 9.1% | 23.3% |
| 净利润同比 | 62.1% | 17.3% |
| 每股收益（稀释后） | $0.03 | $0.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRPLVCEL
| Q4 25 | $140.7M | $92.9M | ||
| Q3 25 | $118.8M | $67.5M | ||
| Q2 25 | $105.1M | $63.2M | ||
| Q1 25 | $104.2M | $52.6M | ||
| Q4 24 | $129.0M | $75.4M | ||
| Q3 24 | $118.6M | $57.9M | ||
| Q2 24 | $120.3M | $52.7M | ||
| Q1 24 | $120.0M | $51.3M |
净利润PRPLVCEL
| Q4 25 | $-3.2M | $23.2M | ||
| Q3 25 | $-11.7M | $5.1M | ||
| Q2 25 | $-17.3M | $-553.0K | ||
| Q1 25 | $-19.1M | $-11.2M | ||
| Q4 24 | $-8.5M | $19.8M | ||
| Q3 24 | $-39.2M | $-901.0K | ||
| Q2 24 | $27.0K | $-4.7M | ||
| Q1 24 | $-50.2M | $-3.9M |
毛利率PRPLVCEL
| Q4 25 | 41.9% | 78.7% | ||
| Q3 25 | 42.8% | 73.5% | ||
| Q2 25 | 35.9% | 73.7% | ||
| Q1 25 | 39.4% | 69.0% | ||
| Q4 24 | 42.9% | 77.6% | ||
| Q3 24 | 29.7% | 71.9% | ||
| Q2 24 | 40.7% | 69.5% | ||
| Q1 24 | 34.8% | 68.9% |
营业利润率PRPLVCEL
| Q4 25 | -1.6% | 24.1% | ||
| Q3 25 | -10.2% | 5.1% | ||
| Q2 25 | -13.5% | -3.2% | ||
| Q1 25 | -13.9% | -24.3% | ||
| Q4 24 | -6.0% | 24.5% | ||
| Q3 24 | -39.5% | -4.3% | ||
| Q2 24 | -12.1% | -11.5% | ||
| Q1 24 | -19.3% | -10.7% |
净利率PRPLVCEL
| Q4 25 | -2.3% | 25.0% | ||
| Q3 25 | -9.9% | 7.5% | ||
| Q2 25 | -16.5% | -0.9% | ||
| Q1 25 | -18.4% | -21.4% | ||
| Q4 24 | -6.6% | 26.3% | ||
| Q3 24 | -33.1% | -1.6% | ||
| Q2 24 | 0.0% | -8.9% | ||
| Q1 24 | -41.8% | -7.5% |
每股收益（稀释后）PRPLVCEL
| Q4 25 | $0.03 | $0.46 | ||
| Q3 25 | $0.11 | $0.10 | ||
| Q2 25 | $0.16 | $-0.01 | ||
| Q1 25 | $0.18 | $-0.23 | ||
| Q4 24 | $0.08 | $0.40 | ||
| Q3 24 | $0.36 | $-0.02 | ||
| Q2 24 | $0.00 | $-0.10 | ||
| Q1 24 | $0.47 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.3M | $137.5M |
| 总债务越低越好 | $126.7M | — |
| 股东权益账面价值 | $-29.7M | $354.6M |
| 总资产 | $296.3M | $488.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PRPLVCEL
| Q4 25 | $24.3M | $137.5M | ||
| Q3 25 | $32.4M | $135.4M | ||
| Q2 25 | $34.2M | $116.9M | ||
| Q1 25 | $21.6M | $112.9M | ||
| Q4 24 | $29.0M | $116.2M | ||
| Q3 24 | $23.4M | $101.7M | ||
| Q2 24 | $23.4M | $102.5M | ||
| Q1 24 | $34.5M | $110.6M |
总债务PRPLVCEL
| Q4 25 | $126.7M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $70.7M | — | ||
| Q3 24 | $50.8M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益PRPLVCEL
| Q4 25 | $-29.7M | $354.6M | ||
| Q3 25 | $-26.9M | $321.9M | ||
| Q2 25 | $-15.6M | $306.8M | ||
| Q1 25 | $1.3M | $295.5M | ||
| Q4 24 | $20.2M | $292.0M | ||
| Q3 24 | $28.0M | $257.5M | ||
| Q2 24 | $66.4M | $243.0M | ||
| Q1 24 | $65.5M | $233.9M |
总资产PRPLVCEL
| Q4 25 | $296.3M | $488.0M | ||
| Q3 25 | $302.1M | $453.3M | ||
| Q2 25 | $303.8M | $435.6M | ||
| Q1 25 | $293.8M | $424.6M | ||
| Q4 24 | $307.8M | $432.7M | ||
| Q3 24 | $309.3M | $390.4M | ||
| Q2 24 | $362.1M | $376.8M | ||
| Q1 24 | $382.1M | $356.7M |
负债/权益比PRPLVCEL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.50× | — | ||
| Q3 24 | 1.82× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.8M | $15.0M |
| 自由现金流经营现金流 - 资本支出 | $-7.8M | $12.8M |
| 自由现金流率自由现金流/营收 | -5.5% | 13.8% |
| 资本支出强度资本支出/营收 | 1.4% | 2.4% |
| 现金转化率经营现金流/净利润 | — | 0.65× |
| 过去12个月自由现金流最近4个季度 | $-41.9M | $24.7M |
8季度趋势，按日历期对齐
经营现金流PRPLVCEL
| Q4 25 | $-5.8M | $15.0M | ||
| Q3 25 | $-968.0K | $22.1M | ||
| Q2 25 | $-4.0M | $8.2M | ||
| Q1 25 | $-23.1M | $6.6M | ||
| Q4 24 | $6.8M | $22.2M | ||
| Q3 24 | $1.1M | $10.2M | ||
| Q2 24 | $-8.9M | $18.5M | ||
| Q1 24 | $-16.8M | $7.2M |
自由现金流PRPLVCEL
| Q4 25 | $-7.8M | $12.8M | ||
| Q3 25 | $-1.8M | $19.5M | ||
| Q2 25 | $-7.0M | $81.0K | ||
| Q1 25 | $-25.3M | $-7.6M | ||
| Q4 24 | $5.7M | $8.5M | ||
| Q3 24 | $101.0K | $-9.2M | ||
| Q2 24 | $-11.0M | $1.8M | ||
| Q1 24 | $-19.9M | $-6.8M |
自由现金流率PRPLVCEL
| Q4 25 | -5.5% | 13.8% | ||
| Q3 25 | -1.5% | 28.8% | ||
| Q2 25 | -6.6% | 0.1% | ||
| Q1 25 | -24.3% | -14.5% | ||
| Q4 24 | 4.4% | 11.2% | ||
| Q3 24 | 0.1% | -15.9% | ||
| Q2 24 | -9.2% | 3.4% | ||
| Q1 24 | -16.5% | -13.3% |
资本支出强度PRPLVCEL
| Q4 25 | 1.4% | 2.4% | ||
| Q3 25 | 0.7% | 3.9% | ||
| Q2 25 | 2.8% | 12.9% | ||
| Q1 25 | 2.2% | 27.0% | ||
| Q4 24 | 0.8% | 18.3% | ||
| Q3 24 | 0.9% | 33.5% | ||
| Q2 24 | 1.7% | 31.8% | ||
| Q1 24 | 2.5% | 27.3% |
现金转化率PRPLVCEL
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | 4.35× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | — | — | ||
| Q2 24 | -330.22× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
